Squamous cell carcinoma of the temporal bone: results and management.
OBJECTIVE
Evaluation of the management and survival of patients treated for temporal bone squamous cell carcinoma.


METHODS
A retrospective analysis.


METHODS
Tertiary care, academic referral center.


METHODS
Twenty-eight patients underwent primary treatment for squamous cell carcinoma of the temporal bone.


METHODS
The patients were staged using the modified Pittsburgh staging system. Patients underwent a local resection, lateral temporal bone resection, or a subtotal lateral temporal bone resection usually followed by radiotherapy.


METHODS
The survival rate of patients grouped by tumor size was calculated.


RESULTS
Staging revealed 12 pT1, 2 pT2, 4 pT3, and 10 pT4 tumors. The mean follow-up was 34 months (2-132 mo). The Kaplan-Meier survival curves showed survival rates at 5 years of 83 and 25% for the stages pT1 and pT4, respectively. The pooled survival curves showed survival rates at 5 years of 85 and 46% for the stages pT1p/T2 and pT3/pT4, respectively.


CONCLUSIONS
Long-term prognosis of the carcinoma of the external auditory canal mainly depends on the stage and primary treatment. Surgery may consist of a lateral temporal bone or subtotal temporal bone resection; in T3 and T4 tumors, resection may be combined with a superficial parotidectomy. If disease is diagnosed in the neck or parotid, then a neck dissection and total parotidectomy may also be performed. Additional radiotherapy should be provided in incompletely resected T1 and all T2 and T3 tumors and part of the T4 tumors. T4 tumors may be treated according to their subclassification based on the anatomic extension.
Department of ENT and HNS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Henricus
H
Kunst
Jean-Pierre
JP
Lavieille
Henri
H
Marres
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection; D009367:Neoplasm Staging; D013506:Otologic Surgical Procedures; D011379:Prognosis; D012189:Retrospective Studies; D012888:Skull Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D013701:Temporal Bone / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents